Breakthrough medical devices: information session, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 April 2026, 15:00 (CEST) to 24 April 2026, 17:00 (CEST)

Human medicines European public assessment report (EPAR): Dazluma, troriluzole, Status: Application withdrawn

ICH E22 General considerations for patient preference studies - Scientific guideline

Appendix 1: Acceptable intakes established for N-nitrosamines

Fee regulation working arrangements

Cookies

Human medicines European public assessment report (EPAR): Hemangiol, propranolol, Date of authorisation: 23/04/2014, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Evfraxy, denosumab, Date of authorisation: 30/06/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Balversa, erdafitinib, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

EMEA-000925-PIP02-10